HHS Secretary Robert F. Kennedy Jr. talked about PBM negotiations Sept. 4 at a Senate Finance Committee hearing. Photo: Senate Finance Committee
Health and Human Services Secretary Robert F. Kennedy Jr.'s decision to remove the chair and vice chair of the U.S. Preventive Services Task Force is drawing attention from health care and benefits leaders because the panel plays a central role in determining which preventive services insurers must cover at no cost to patients under the Affordable Care Act.
The independent advisory body evaluates clinical evidence and assigns grades to preventive services based on the strength of health benefits. Under ACA rules, insurers are generally required to cover services receiving an "A" or "B" recommendation without patient cost-sharing.
Those recommendations shape coverage for services including mammograms, colonoscopies, lung cancer screenings, depression screenings, statin therapy for cardiovascular disease prevention and HIV prevention medication such as PrEP.
Kennedy removed task force chair Dr. John Wong, a primary care physician and researcher affiliated with Tufts Medical Center, and vice chair Dr. Esa Davis, a preventive medicine physician and associate vice president for community health at the University of Maryland, Baltimore, before the end of their terms.
According to multiple reports, HHS described the dismissals as administrative and not performance-related. Kennedy has defended broader changes to federal health advisory bodies as necessary to improve transparency and accountability. In congressional testimony last month, he said the task force had been "lackadaisical and negligent for 20 years" and promised more frequent meetings and greater transparency.
The move drew criticism from organized medicine. The American Medical Association said it was "extremely concerned" by the removals and urged HHS to preserve the task force's "long-standing, transparent process" for selecting members.
The shakeup follows other restructuring efforts across federal health advisory bodies. Earlier this year, HHS replaced members of the CDC's Advisory Committee on Immunization Practices, a panel whose recommendations also influence insurance coverage decisions.
The task force has long operated as an independent panel of volunteer experts in evidence-based preventive care. Its recommendations directly affect insurers, employers and health care providers because they determine coverage requirements and shape long-term spending on early detection and chronic disease prevention.
The dismissals come amid ongoing uncertainty for the panel, which has reportedly not met for more than a year and has multiple vacant seats. The controversy also follows the Supreme Court's decision in Kennedy v. Braidwood Management, which preserved the ACA's preventive-services framework while affirming HHS oversight authority over the task force.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.